STE - CIK 0001757898
The table below shows STERIS plc's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|
| Operating cash flow | $420.00M | - | $303.70M | - | - | $281.13M |
| Capital expenditure | $93.60M | - | $108.10M | - | - | $66.60M |
| Investing cash flow | -$108.50M | - | $687.80M | - | - | -$66.60M |
| Dividends paid | $56.20M | - | $51.40M | - | - | $46.43M |
STERIS plc reported operating cash flow of $1.15B for fiscal year 2025. That is up 18.0% from $973.27M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow grew from $424.09M (FY 2017) to $1.15B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $10.60M | $46.42M | $64.20M | $2.23M | $489.00K | $8.72M |
| Financing cash flow | -$213.10M | - | -$998.90M | - | - | -$213.64M |